ENTERO · Entero Healthcare Solutions Limited · Financials
Volume · Nov 13
5450
Avg daily vol (3M)
41.56K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.
Revenue
65.91B
+29.3%
FY2026
Net Income
1.15B
+21.3%
FY2026
Operating Cash Flow
962.01M
+225.2%
FY2026
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2026 | FY2025 | FY2024 |
|---|---|---|---|---|
| INR | 76.44B | 65.91B | 50.96B | 39.22B |
| INR | 500.24M | 432.93M | 306.92M | 250.17M |
| INR | 750.32M | 543.85M | 416.22M | 656.84M |
| INR | 2.44B | 1.79B | 1.39B | 355.54M |
| INR | 520.54M | 334.96M | 313.05M | -42.44M |
| INR | 1.39B | 1.15B | 948.2M | 391.09M |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2024–FY2026: 0 in dividends.
Debt Profile
No verified debt profile is available yet. This does not establish that the company has no debt or covenants.